SCHEMBL22632089

SCHEMBL22632089

CCOC(=O)Nc1ccc2c(CCNC(C)=O)cc(=O)oc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.67
▸ HPGD P15428 7/20 0.67
▸ KDM4E B2RXH2 6/20 0.67
▸ HSD17B10 Q99714 4/20 0.67
▸ NPC1 O15118 3/20 0.67
▸ RAB9A P51151 2/20 0.67
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ RXFP1 Q9HBX9 1/20 0.60
▸ TDP1 Q9NUW8 1/20 0.58
▸ GAA P10253 2/20 0.58
▸ POLB P06746 2/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ CASP3 P42574 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ SENP6 Q9GZR1 1/20 0.55
▸ MTNR1A P48039 3/20 0.54
▸ MTNR1B P49286 3/20 0.54
▸ USP2 O75604 1/20 0.54
▸ CA12 O43570 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22632085 0.89 ALDH1A1 (0.69) ALDH1A1HPGDKDM4EHSD17B10NPC1
SCHEMBL24623218 0.89 ALDH1A1 (0.63) ALDH1A1HPGDKDM4EHSD17B10NPC1
SCHEMBL24623222 0.86 HPGD (0.65) ALDH1A1HPGDKDM4EHSD17B10NPC1
SCHEMBL6227542 0.83 ALDH1A1 (0.74) ALDH1A1HPGDKDM4EHSD17B10NPC1
SCHEMBL12987100 0.81 ALDH1A1 (1.00) ALDH1A1HPGDKDM4EHSD17B10NPC1
SCHEMBL22632322 0.78 MTNR1A (0.82) ALDH1A1HPGDKDM4EGAAMTNR1A
SCHEMBL22632306 0.77 MTNR1B (0.53) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL22632226 0.77 MTNR1B (0.60) ALDH1A1HPGDKDM4EHSD17B10RAB9A
SCHEMBL24623271 0.76 POLB (0.53) ALDH1A1HPGDKDM4EHSD17B10NPC1
SCHEMBL22632228 0.75 MTNR1A (0.58) ALDH1A1HPGDKDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback